Xingi, E. Smirlis, D. Myrianthopoulos, V. Magiatis, P. Grant, K.M. Meijer, L. Mikros, E. Skaltsounis, A.-L. Soteriadou, K., 6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis, International Journal for Parasitology, (39), 1289-1303, 2009, 0020-7519